Most patients with colorectal carcinoma will develop liver metastases. Radiofrequency ablation (RFA) has been utilized in metastatic CRC to help improve the survival gap between resectable and unresectable tumor.
Methods
The current use of RFA in selected patient populations is reviewed.
Results
RFA provides a survival benefit in patients with unresectable hepatic metastases from CRC compared with chemotherapy alone. It offers effective local tumor destruction in appropriately selected lesions and minimizes the morbidity and mortality of an open resection. Common complications are abdominal bleeding (1.6%), abdominal infection (1.1%), and injury to the biliary tree (1.0%). Mortality ranges from 0% to 0.5%.
Conclusions
Trials are underway to compare chemotherapy plus local ablation to chemotherapy alone. RFA is a tool that should be utilized by experienced individuals to achieve optimal oncologic outcomes.
References
1.
WagnerJ.S., AdsonM.A., van HeerdenJ.A.The natural history of hepatic metastases from colorectal cancer: a comparison with resective treatment. Ann Surg.1984; 199: 502–508.
2.
GilbertH.A., KaganA.R.Metastases: incidence, detection, and evaluation without histologic confirmation. In: WeissL., ed. Fundamental Aspects of Metastasis.Amsterdam, The Netherlands: North Holland Publishing Co; 1976: 385–405.
3.
Registry of Hepatic Metastases.Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery.1988; 103: 278–288.
4.
NordlingerB., GuiguetM., VaillantJ.C.Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chiru. Cancer.1996; 77: 1254–1262.
5.
FongY., FortnerJ., SunR.L.Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg.1999; 230: 309–321.
6.
GayowskiT.J., IwatsukiS., MadariagaJ.R.Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery.1994; 116: 703–711.
7.
AbdallaE.K., VautheyJ.N., EllisL.M.Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg.2004; 239: 818–827.
8.
de GramontA., FigerA., SeymourM.Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol.2000; 18: 2938–2947.
9.
SaltzL.B., CoxJ.V., BlankeC.Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med.2000; 343: 905–914.
10.
NiY., MulierS., MiaoY.A review of the general aspects of radiofrequency ablation. Abdom Imaging.2005; 30: 381–400.
11.
SolbiatiL., LivraghiT., GoldbergS.N.Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology.2001; 221: 159–166.
12.
SipersteinA., GarlandA., EngleK.Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol.2000; 7: 106–113.
13.
de BaereT., EliasD., DromainC.Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Radiol.2000; 175: 1619–1625.
14.
MulierS., MulierP., NiY.Complications of radiofrequency coagulation of liver tumors. Br J Surg.2002; 89: 1206–1222.
15.
LivraghiT., SolbiatiL., MeloniF.Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test of time” approach. Cancer.2003; 97: 3027–3035.
16.
CurleyS.A., IzzoF., DelrioP.Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg.1999; 230: 1–8.
17.
MulierS., NiY., JamartJ.Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg.2005; 242: 158–171.
18.
BerberE., PelleyR., SipersteinA.E.Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol.2005; 23: 1358–1364. Epub 2005 Jan 31.
19.
OshowoA., GillamsA., HarrisonE.Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg.2003; 90: 1240–1243.
20.
AdamR., DelvartV., PascalG.Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg.2004; 240: 644–658.
